| Total | Non-MAFLD | MAFLD | p-value |
---|---|---|---|---|
Participants (n) | 98,685 | 67,930 | 30,755 | Â |
Age,year | 51.88 ± 12.64 | 51.48 ± 13.12 | 52.75 ± 11.49 | < 0.01 |
Male, N(%) | 78,893(79.94) | 53,697(79.05) | 25,196(81.92) | < 0.01 |
Mean follow-up time,year | 14.01(13.63–14.19) | 14.00(13.63–14.19) | 14.01(13.61–14.20) | 0.24 |
SBP, mmHg | 131.09 ± 21.05 | 128.24 ± 20.49 | 137.36 ± 20.92 | < 0.01 |
DBP, mmHg | 83.51 ± 11.79 | 81.78 ± 11.37 | 87.35 ± 11.79 | < 0.01 |
TG, mmol/L | 1.27(0.90–1.93) | 1.12(0.80–1.60) | 1.77(1.23–2.67) | < 0.01 |
BMI, Kg/m2 | 25.05 ± 3.49 | 23.94 ± 3.05 | 27.50 ± 3.14 | < 0.01 |
FBG, mmol/L | 5.11(4.66–5.71) | 5.04(4.60–5.56) | 5.36(4.81–6.16) | < 0.01 |
HDL-C, mmol/L | 1.50(1.28–1.77) | 1.51(1.29–1.77) | 1.48(1.26–1.74) | < 0.01 |
WC,cm |  |  |  | < 0.01 |
female | 83.06 ± 10.73 | 80.24 ± 10.01 | 90.27 ± 9.01 |  |
males | 83.06 ± 9.57 | 85.67 ± 9.02 | 93.24 ± 8.62 |  |
Hs-CRP,mg/L | 0.80(0.30–2.20) | 0.69(0.26–1.82) | 1.20(0.50–3.01) | < 0.01 |
Current smoker, N (%) | 34,018(34.47) | 23,311(34.32) | 10,707(34.81) | 0.13 |
Current drinker, N (%) | 40,818(41.36) | 27,480(40.45) | 13,338(43.37) | < 0.01 |
Physical activity, N(%) | 90,075(91.28) | 61,874(91.08) | 28,201(91.70) | < 0.01 |
Education level, N(%) |  |  |  | < 0.01 |
≤junior high school | 78,655(79.70) | 53,970(79.45) | 24,685(80.26) |  |
≥senior high school | 20,030(20.30) | 13,960(20.55) | 6070(19.74) |  |
Salt level, g/d |  |  |  | < 0.01 |
< 6 | 9163(9.29) | 6472(9.53) | 2691(8.75) |  |
6–10 | 78,843(79.89) | 54,436(80.14) | 24,407(79.36) |  |
> 10 | 10,679(10.82) | 7022(10.34) | 3657(11.89) |  |
Antihypertensive treatment, N(%) | 11,029(11.18) | 5762(8.48) | 5267(17.13) | < 0.01 |
Antidiabetic treatment, N (%) | 2420(2.45) | 1221(1.80) | 1199(3.90) | < 0.01 |
Lipid-lowering treatment, N (%) | 925(0.94) | 431(0.63) | 494(1.61) | < 0.01 |
hypertension | 37,128(37.62) | 21,380(31.47) | 15,748(51.20) | < 0.01 |
diabetes | 9336(9.46) | 4278(6.30) | 5058(16.45) | < 0.01 |